Cannabinoids and the Coronavirus.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed.

1. Selected Cannabinoids, Cannabimimetic Agents andPharmaceuticals (Basel, Switzerland) · 2026
   Review
2. Immunomodulatory effects of cannabinoids against viral infections: a review of its potential use in SARS-CoV2 infection.Virusdisease · 2024
   Review
3. Endocannabinoid System: Chemical Characteristics and Biological Activity.Pharmaceuticals (Basel, Switzerland) · 2023
   Review
4. Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review.Frontiers in immunology · 2023
   Review
5. Identification of SARS-CoV-2 Main Protease Inhibitors from a Library of Minor Cannabinoids by Biochemical Inhibition Assay and Surface Plasmon Resonance Characterized Binding Affinity.Molecules (Basel, Switzerland) · 2022
   Article
6. Analyzing sentiments and themes on cannabis in Canada using 2018 to 2020 Twitter data.Journal of cannabis research · 2022
   Article
7. Cannabinoids: Therapeutic Use in Clinical Practice.International journal of molecular sciences · 2022
   Review
8. The Medicinal Natural Products ofMolecules (Basel, Switzerland) · 2022
   Review
9. A review of natural products, their effects on SARS-CoV-2 and their utility as lead compounds in the discovery of drugs for the treatment of COVID-19.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2022
   Review
10. Antimicrobial and Antiviral (SARS-CoV-2) Potential of Cannabinoids andMolecules (Basel, Switzerland) · 2021
    Review
11. Electrochemical sensing: A prognostic tool in the fight against COVID-19.Trends in analytical chemistry : TRAC · 2021
    Review
12. Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19.International journal of molecular sciences · 2021
    Review
13. Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches.International journal of biological macromolecules · 2021
    Article
14. Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?Turkish journal of biology = Turk biyoloji dergisi · 2021
    Article
15. Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders?Cannabis and cannabinoid research · 2021
    Review
16. SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing.Immunity & ageing : I & A · 2020
    Review
17. Potentials of plant-based substance to inhabit and probable cure for the COVID-19.Turkish journal of biology = Turk biyoloji dergisi · 2020
    Article
18. Cannabis and COVID-19: Reasons for Concern.Frontiers in psychiatry · 2020
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.